US adds some-more on clot risk to some birth control pills

<p>WASHINGTON (Reuters) – U.S. health regulators are adding information to a labels on a renouned category of <span>birth control pills</span> that includes Bayer AG’s Yaz and Yasmin, to uncover they might lift a risk of <span>blood clots</span>.</p>
<p> All common birth control pills boost a woman’s chances of removing potentially deadly blood clots.</p>
<p> But a <span>U.S. Food and Drug Administration</span> pronounced on Tuesday that some studies showed a risk might be even aloft for some-more new pills that enclose a devalue <span>drospirenone</span>, a fake hormone.</p>
<p> “The revised drug labels will news that some epidemiologic studies reported as high as a three-fold boost in a risk of blood clots for drospirenone-containing products … given other epidemiological studies found no additional risk,” a <span>FDA</span> pronounced in a stat...